Merck to slash annual costs by $2.5 billion, cut 8,500 jobs
(Reuters) - Merck & Co, taking a cue from rival drugmakers that have slashed research spending to bolster earnings, said it will cut annual operating costs by $2.5 billion and...
Home > Reviews
All Stories
Lilly mulls options as Medicare shuns Alzheimer’s diagnostic
(Reuters) - Eli Lilly and Co on Monday said the federal government has unfairly blocked patient access to its Amyvid diagnostic test for Alzheimer's disease by denying reimbursement for such...
Lilly mulls options as Medicare shuns Alzheimer’s diagnostic
(Reuters) - Eli Lilly and Co on Monday said the federal government has unfairly blocked patient access to its Amyvid diagnostic test for Alzheimer's disease by denying reimbursement for such...
J&J puts Chinese businesses under local chairman
(Reuters) - Johnson & Johnson said on Tuesday the business heads of its three Chinese operations would begin to report to one local chairman next month in an effort to...
Lilly defends blockbuster Alimta with unusual ammo
(Reuters) - Eli Lilly and Co, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds...
Lilly defends blockbuster Alimta with unusual ammo
(Reuters) - Eli Lilly and Co, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds...
Intuitive cuts sales, surgery forecasts, hit by FDA warning
(Reuters) - Intuitive Surgical Inc shares fell 11 percent after the company slashed its 2013 sales forecast due to disappointing demand for its da Vinci surgical robots and procedures, and...
Eli Lilly to freeze employee base pay ahead of generic onslaught
NEW YORK (Reuters) - U.S. drugmaker Eli Lilly & Co , which expects to lose about 20 percent of its global revenue next year due to the expiration of key...
Johnson & Johnson results beat forecasts; Elan share sale helps
(Reuters) - Johnson & Johnson on Tuesday reported higher-than-expected quarterly earnings on strong demand for its prescription drugs and medical devices, but a big gain from the sale of a...
FDA probes deaths of two patients on Lilly schizophrenia drug
(Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co's long-acting treatment for schizophrenia, Zyprexa Relprevv. Both...